3-IPA Purification via Calcium Salt Precipitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing 3-(3-indolyl)propionic acid (3-IPA) are inefficient due to high costs, impurities, and the need for large solvent volumes, making it unsuitable for large-scale pharmaceutical production.
Innovation Solution
The use of the calcium salt of 3-IPA, which has lower water solubility than other salts, allows for easier purification and removal of contaminants, enabling the production of substantially pure 3-IPA through conversion to and from its calcium salt form.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If the standard one-step one-pot synthesis method using indole, acrylic acid, acetic anhydride and acetic acid is used, then the production process is simple, but the yield is low and the product purity is poor requiring extensive purification
Solution Approach 1:
The patent introduces an intermediate purification step where the crude reaction product is converted to its calcium salt form, which precipitates from the aqueous solution. This intermediate calcium salt acts as a mediator that separates the desired product from soluble impurities (acrylic acid, acetic acid) through selective precipitation, enabling subsequent conversion to pure 3-IPA without extensive recrystallization
Solution Approach 2:
The patent changes the chemical form of the product from free acid to calcium salt during purification. By converting 3-IPA to its calcium salt intermediate, the solubility characteristics change dramatically, allowing the salt to precipitate from aqueous solution while impurities remain soluble. This parameter change (acid to salt conversion) enables efficient separation and purification
2Manufacturing precision
If extensive purification steps including multiple recrystallizations are performed to achieve pharmaceutical grade purity, then the product purity is improved, but the time consumption and solvent usage increase significantly
Solution Approach 1:
The calcium salt intermediate serves as a purification mediator that selectively precipitates from the reaction mixture. This single intermediate step replaces multiple time-consuming recrystallization operations, achieving pharmaceutical grade purity (99.5% or higher) in one operation rather than through extensive sequential purification steps
Solution Approach 2:
The patent exploits the phase transition of 3-IPA calcium salt from dissolved state to solid precipitate. By adjusting the reaction conditions, the calcium salt transitions from soluble to insoluble phase, allowing easy separation by filtration. This phase transition approach is more efficient than repeated solid-liquid equilibria operations like recrystallization
3Manufacturing precision
If multiple recrystallization steps are used to purify 3-IPA, then the product purity is improved, but the volume of solvents required for crystallization increases significantly
Solution Approach 1:
The calcium salt intermediate acts as a purification mediator that enables separation without requiring large volumes of crystallization solvents. The salt precipitates from the aqueous reaction medium itself, using the reaction water as the purification medium rather than requiring additional organic solvents for recrystallization
Solution Approach 2:
The patent utilizes the insolubility of calcium salt in water to achieve purification through aqueous precipitation rather than organic solvent recrystallization. This phase transition approach eliminates the need for large volumes of organic solvents, reducing both cost and environmental impact while achieving high purity product
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method improves the yield and purity of 3-IPA, reducing the need for extensive solvent use and costly purification processes, making it suitable for pharmaceutical applications.
Implementation Method 1
The use of the calcium salt of 3-IPA, which has lower water solubility than other salts, allows for easier purification and removal of contaminants
Data Source
AI summary
Substantially pure 3-(3-indolyl)propionic acid free acid is synthesized by converting the free acid to 3-(3-indolyl)propionic acid calcium salt (3-IPA calcium), precipitating and washing, and then reconverting the 3-IPA calcium to the free acid. 3-IPA calcium is suitable for use in pharmaceutical compositions in tablet and sustained-release dosage forms. 3-IPA calcium can be used to inhibit the cytotoxic effects of amyloid beta protein on cells, to treat fibrillogenic diseases in a mammal, and to treat diseases or conditions in which free radicals or oxidative stress plays a role.